Journal article
Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease.
Abstract
The discovery of biomarkers for the onset of Alzheimer's disease (AD) is essential for disease modification strategies. To date, AD biomarker studies have focused on brain imaging and cerebrospinal fluid (CSF) changes in amyloid- β (Aβ) peptide and tau proteins. While reliable to an extent, this panel could be improved by the inclusion of novel biomarkers that optimize sensitivity and specificity. In this study, we determined whether CSF levels …
Authors
Counts SE; He B; Prout JG; Michalski B; Farotti L; Fahnestock M; Mufson EJ
Journal
Current Alzheimer Research, Vol. 13, No. 7, pp. 800–808
Publisher
Bentham Science Publishers
Publication Date
2016
DOI
10.2174/1567205013666160129095649
ISSN
1567-2050